Summary
Bone mineralization changes with age and disease. The distribution of mineral particles in a given bone (mineralization profile) has been studied using density fractionation as well as microradiography and electron backscattering imaging. The biological determinant of mineralization is the rate of turnover. During rapid growth and periods of high remodeling, mineralization is shifted towards lower mineral density (hypomineralization). During aging and periods of low remodeling, mineralization is shifted towards higher mineral densities (hypermineralization). Chemicals can also influence the mineralization profile of bone. Fluoride induces hypermineralization by stabilizing the apatite lattice and reducing bone mineral solubility, whereas strontium induces hypomineralization by loosening the apatite lattice and increasing bone mineral solubility. Drugs such as bisphosphonates induce hypermineralization by inhibiting resorption and acting as crystal poison. Finally, mineralization can be impaired by defects as in rickets and osteomalacia or made excessive by continuous accretion of mineral without resorption as in osteopetrosis.
Similar content being viewed by others
References
Amprino E, Engstrom A (1952) Studies on X-ray absorption and diffraction of bone tissues. Acta Anat 15:1–22
Boyde A, Jones SJ (1983) Backscattered electron imaging of skeletal tissues. Metab Bone Dis Rel Res 5:145–150
Bonar LC, Roufosse AH, Sabine WK, Grynpas MD, Glimcher MJ (1983) X-ray diffraction studies of the crystallinity of bone mineral in newly synthesized and density fractionated bone. Calcif Tissue Int 35:202–203
Boskey AL, Marks SC Jr (1985) Mineral and matrix alterations in the bones of incisors-absent(ialia) osteopetrotic rats. Calcif Tissue Int 37:287–292
Grynpas MD, Hunter GK (1988) Bone mineral and glycosaminoglycans in newborn and mature rabbits. J Bone Miner Res 3:159–164
Martin RB, Pickett JC, Zinaich S (1980) Studies of skeletal remodelling in aging men. Clin Orthop Rel Res 149:268–282
Laval-Jeantet A, Bergot C, Carroll R, Garcia-Schaefer F (1983) Cortical bone senescence and mineral bone density of the humerus. Calcif Tissue Int 35:268–272
Lindhal O, Lindgarden AGH (1967) Cortical bone in man. Acta Orthop Scand 38:133–140
Thompson DD (1980) Age changes in bone mineralization, cortical thickness, and haversian canal area. Calcif Tissue Int 31:5–11
Dequeker J (1975) Bone and aging. Ann Rheum Dis 34:100-115 11. Sharpe WD (1979) Age changes in human bone: an overview. Bull NY Acad Med 55:757–773
Joswey J, Reiss E, Canterbury JM (1974) Long-term effect of high phosphate intake on parathyroid hormone levels and bone metabolism. Acta Orthop Scand 45:801–808
Barbos MP, Bianco P, Ascenzi A (1983) Distribution of osteonic and interstitial components in the human femoral shaft with reference to structure, calcification and mechanical properties. Acta Anat 115:178–186
Pankovich AM, Simmons DJ, Kilkarni VV (1974) Zonal osteons in cortical bone. Clin Orthop Rel Res 100:356–363
Trotter M, Dickson BB (1974) Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 179:118
Lacroix P, Dhem A (1967) Le Vieillisement des Os Belge. Orthop 33:745–760
Atkinson PJ (1969) Structural aspects of aging bone. Gerontologia 15:171–173
Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Flannon WM (1982) Effect of osteoporosis. N Engl J Med 8:446–450
Mazess RB (1982) On aging bone loss. Clin Orthop Rel Res 165:239–252
Phillips HB, Owen-James S, Chandler B (1978) Quantitative histology of bone: a computerized method of measuring the total mineral content of bone. Calcif Tissue Res 26:85–89
Pugliese LR, Anderson C (1986) A method for the determination of the relative distribution and relative quantity of mineral in bone sections. J Histotechnology 9:91–93
Reid SA, Boyde A (1987) Changes in the mineral density distribution in human bone with age: image analysis using backscattered electrons in the SEM. J Bone Miner Res 2:13–22
Boyce TM, Bloebaum RD, Bachus KN, Skedros JG (1990) Reproducible method for calibrating the backscattered signal for quantitative assessment of mineral content in bone. Scanning Microsc 4:591–603
Simmons ED, Pritzker KPH, Grynpas MD (1991) Age-related changes in human cortical bone. J Orthop Res 9(2):155–167
Glimcher MJ (1976) The composition, structure, and organization of bone and other mineralized tissue and the mechanisms of calcification. In: Grrep RO, Astwood EB (eds) Handbook of physiology: endocrinology, vol. 7. Am Phys Soc, Washington DC, pp 25–113
Robinson AA (1952) An electron microscope study of the crystalline inorganic component of bone and its relationship to the organic matrix. J Bone Joint Surg 34A:389–434
Richell LJ (1967) Contribution à L'étude du Mètabolisme Mineral de l'os Chez le Rat. PhD Thesis, University of Liège, Liège
Albright F, Reifenstein EC (1948) The parathyroid glands and metabolic bone disease. Williams and Wilkins (ed). Baltimore, MD, p 393
Frost HM (1985) The pathomechanics of osteoporoses. Clin Orthop Rel Res 200:198–225
Parfitt AM (1981) Bone remodelling in the pathogenesis of osteoporosis. Res Staff Phys Dec.:60–66, 71–72
Heaney RP (1992) The natural history of vertebral osteoporosis. Is low bone mass an epiphenomenon? Bone 13:S23-S26.
Heaney RP, Avioli LV, Chesnut C II, Brandenburger GH, Lappe J, Recker RR (1989) Osteoporotic bone fragility. Detection by ultrasound transmission velocity. JAMA 261:2986–2990
Melton LJ II, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL (1989) Epidemiology of vertebral fractures in women. Am J Epidemiol 129:1000–1011
Chantraine A, Nusgens B, Lapiere ChM (1986) Bone remodelling during the development of osteoporosis in paraplegia. Calcif Tissue Int 38:323–327
Grynpas MD, Alpert B, Lieberman I, Katz I, Pritzker KPH (1991) Subchondral bone in osteoarthritis. Calcif Tissue Int 49:20–26
Utoff HK, Jaworski ZFG (1978) Bone loss in response to longterm immobilization. J Bone Joint Surg 60(B):420–429
Burkhart JM, Jowsey J (1967) Parathyroid and thyroid hormones in the development of immobilization osteoporosis. Endocrinology 81:1053–1062
Wronski TJ, Yen C-F (1991) The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Material (suppl) 1:69–75
Kimmel DB (1991) The oophorectomized beagle as an experimental model for estrogen-depletion bone loss in the adult human. (suppl) Cells Materials 1:75
Whiting SJ, Draper H (1980) The role of sulfate in the calcuria of high protein diets in adult rats. J Nutrition 110:212–222
Barzel US (1975) Studies on osteoporosis: the long-term effect of oophorectomy and of ammonium chloride ingestion on the bone of mature rats. Endocrinology 96:1304–1306
Bressot C, Coupron P, Edouard C, Meurnier P (1976) Histomorphometrie des Osteophaties Endocriniennes, Ph.D. Thesis, Lyon, France
Thompson R (1973) Heparin osteoporosis. J Bone Joint Surg 55A(3):606–612
Bauss F, Minne HW, Sterz H, Weng V, Wesh H, Ziegler R (1985) Comparative bone analysis via inflammation-mediated osteopenia in the rat. Calcif Tissue Int 37:539–546
Dickson IR, Kodicek E (1979) Effect of vitamin D deficiency on bone formation in the chick. Biochem J 182:429–435
Aitken JM (1976) Factors affecting the distribution of zinc in the human skeleton. Calcif Tissue Res 20:23–30
Lei KY, Young LC (1978) Mineral content of bone and other tissues. In: Bowden DM (ed) Aging in nonhuman primates. Van Nostrand, New York, pp 348–355
Burnell JM, Baylink DJ, Chesnut CH, Tuebner E (1986) The role of skeletal caclium deficiency in postmenopausal osteoporosis. Calcif Tissue Int 38:187–192
Harrison JE, Bayley TA, Josse RG, Murray TM, Sturtridge W, Williams C, Goodwing S, Tam C, Fornasier V (1986) The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis. Bone Miner 1:321–333
Grynpas MD, Marie P (1990) Low doses of stable strontium alter the quality and quantity of bone in rats. Bone 11:313–319
Posner AS, Eanes ED, Harper RA (1963) X-ray diffraction analysis of the effect of fluoride on human bone apatite. Arch Oral Biol 8:549–570
Grynpas MD, Pritzker KPH, Simmons ED, Hancock RGV, Harrison JE (1986) In: Ali Y (ed) Is fluoridated bone different from non-fluoridated bone? Cell-mediated calcification and matrix vesicles. Elsevier Science, New York, pp 409–414
Grynpas MD, Cheng P-T (1988) Fluoride reduces the rate of dissolution of bone. Bone Miner 5:1–9
Ericsson Y, Ekberg O (1975) Dietetically provoked general alveolar osteopenia in rat and its prevention or cure by calcium and fluoride. J Periodont Res 10:256–269
Bang S (1978) Effects of fluoride on the chemical composition of inorganic bone substance. In: Courvoisier B, Donath A, Baud CA (eds) Hans Huber, Bern, pp 56–61
Turner CH, Akhter MP, Heaney RP (1992) The effects of fluoridated water on bone strength. J Orthop Res 10:581–587
Legeros RZ, Quirologico G, Legeros JP (1979) Incorporation of strontium in apatite: effect of pH. J Dent Res 58(A):169
Skornya SC (1981) Effects of oral supplementation with stable strontium. Can Med Assoc J 125:703–712
Skornya SC (1984) Metabolic aspects of the pharmacologic use of trace elements in human subjects with specific reference to stable strontium. Trace Subst Environ Health 18:3–23
Marie PJ, Garba MT, Hott M, Miravet L (1985a) Effect of low doses of stable strontium on bone metabolism in rats. Miner Electrolyte Metab 11:5–13
Marie PJ, Hott M, Garba MT (1985b) Contrasting effect in 1.25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse. Metabolism 34(8):777–783
Matsumoto A (1976) Effect of strontium on the epiphyseal cartilage plate of rat tibiae. Jpn J Pharmacol 26:675–681
Johnson AR (1973) The influence of strontium on characteristic factors of bone. Calcif Tissue Res 11:215–221
Ott SM, Maloney NA, Coburn JW, Algrey AC, Sherrard DJ (1982) The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307:136
Blumenthal NC, Posner AS (1984) In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth. Calcif Tissue Int 36:439
Francis MD, Martodam RR (1983) Chemical, biochemical and medicinal properties of the diphosphonates. In: Hildebrand RL (ed) The role of phosphonates in living systems. Boca Raton, CRC Press, pp 55–96
Jung A, Bisaz S, Bartholdi P, Fleisch H (1973) Influence of pyrophosphate on the exchange of calcium and phosphate ions on hydroxyapatite. Calcif Tissue Res 13:27–40
Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P (1983) Structure-activity relationship of various biphosphates. Calcif Tissue Int 35:87–89
Riggs BL, Wahner HW, Seeman E, Offord KP, Dunn WL, Mazess RB, Johnson KA, Melton LJ (1982) Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest 70:716–723
Grynpas MD (1989) Bone quality and quantity. Future Health 11(1):7–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grynpas, M. Age and disease-related changes in the mineral of bone. Calcif Tissue Int 53 (Suppl 1), S57–S64 (1993). https://doi.org/10.1007/BF01673403
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01673403